Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
UBS
Healthtrust
Federal Trade Commission
Harvard Business School
Medtronic
McKesson
Farmers Insurance
Mallinckrodt
Boehringer Ingelheim

Generated: August 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072024

« Back to Dashboard
NDA 072024 describes METAPROTERENOL SULFATE, which is a drug marketed by Apotex Inc, Wockhardt, Mylan Speciality Lp, DEY, Usl Pharma, Watson Labs, Astrazeneca, Teva, Par Pharm, Nephron, Silarx, G And W Labs Inc, Am Therap, and Morton Grove, and is included in twenty-nine NDAs. It is available from two suppliers. Additional details are available on the METAPROTERENOL SULFATE profile page.

The generic ingredient in METAPROTERENOL SULFATE is metaproterenol sulfate. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the metaproterenol sulfate profile page.

Summary for NDA: 072024

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 072024

Mechanism of ActionAdrenergic beta2-Agonists

Suppliers and Packaging for NDA: 072024

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METAPROTERENOL SULFATE
metaproterenol sulfate
TABLET;ORAL 072024 ANDA Par Pharmaceutical Inc 49884-258 49884-258-01 100 TABLET in 1 BOTTLE (49884-258-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Jun 28, 1988TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Queensland Health
Citi
Julphar
McKesson
Deloitte
Cipla
Federal Trade Commission
US Department of Justice
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot